Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
McGowan Institute for Regenerative Medicine, Departments of Surgery and Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
J Biomed Mater Res A. 2024 Feb;112(2):276-287. doi: 10.1002/jbm.a.37622. Epub 2023 Sep 29.
In pursuit of a suitable scaffold material for cardiac valve tissue engineering applications, an acellular, electrospun, biodegradable polyester carbonate urethane urea (PECUU) scaffold was evaluated as a pulmonary valve leaflet replacement in vivo. In sheep (n = 8), a single pulmonary valve leaflet was replaced with a PECUU leaflet and followed for 1, 6, and 12 weeks. Implanted leaflet function was assessed in vivo by echocardiography. Explanted samples were studied for gross pathology, microscopic changes in the extracellular matrix, host cellular re-population, and immune responses, and for biomechanical properties. PECUU leaflets showed normal leaflet motion at implant, but decreased leaflet motion and dimensions at 6 weeks. The leaflets accumulated α-SMA and CD45 positive cells, with surfaces covered with endothelial cells (CD31+). New collagen formation occurred (Picrosirius Red). Accumulated tissue thickness correlated with the decrease in leaflet motion. The PECUU scaffolds had histologic evidence of scaffold degradation and an accumulation of pro-inflammatory/M1 and anti-inflammatory/M2 macrophages over time in vivo. The extent of inflammatory cell accumulation correlated with tissue formation and polymer degradation but was also associated with leaflet thickening and decreased leaflet motion. Future studies should explore pre-implant seeding of polymer scaffolds, more advanced polymer fabrication methods able to more closely approximate native tissue structure and function, and other techniques to control and balance the degradation of biomaterials and new tissue formation by modulation of the host immune response.
为了寻找适合心脏瓣膜组织工程应用的支架材料,我们评估了一种去细胞、电纺、可生物降解的聚酯碳酸酯氨酯脲(PECUU)支架作为体内肺动脉瓣叶置换物的效果。在绵羊(n=8)中,单个肺动脉瓣叶被 PECUU 瓣叶置换,并在 1、6 和 12 周时进行随访。通过超声心动图评估植入瓣叶的功能。对植入的样本进行大体病理、细胞外基质的微观变化、宿主细胞再定植和免疫反应以及生物力学特性的研究。PECUU 瓣叶在植入时显示出正常的瓣叶运动,但在 6 周时瓣叶运动和尺寸减小。瓣叶积累了α-SMA 和 CD45 阳性细胞,表面覆盖着内皮细胞(CD31+)。发生了新的胶原蛋白形成(苦味酸红)。组织厚度的增加与瓣叶运动的减少相关。PECUU 支架在体内具有支架降解的组织学证据,并且随着时间的推移,促炎/M1 和抗炎/M2 巨噬细胞的积累。炎症细胞积累的程度与组织形成和聚合物降解相关,但也与瓣叶增厚和瓣叶运动减少相关。未来的研究应探索聚合物支架的植入前接种、更先进的聚合物制造方法,以更接近天然组织的结构和功能,以及其他控制和平衡生物材料降解和新组织形成的技术,通过调节宿主免疫反应来实现。